Document is current
Any future updates will be listed below
-
Authors
Silva, Isabel C.
Daher, Rachel
Khattri, Saakshi
- License Information
-
More Information
Article History
Received: 11 February 2025
Revised: 17 March 2025
Accepted: 21 March 2025
First Online: 5 April 2025
Declarations
:
: Institutional Review Board of the Mount Sinai School of Medicine, in accordance with Mount Sinai’s Federal Wide Assurances (FWA#00005656, FWA#00005651) to the Department of Health and Human Services approved the following human subject research.
: Author SK is an employee of Mount Sinai and receives research funds from Leo Pharma, Abbvie, Bristol Myers Squibb, Pfizer, Celgene, and Acelyrin. SK is also a consultant for Leo, Abbvie, Eli Lilly, Janssen, Regeneron, Sanofi, and UCB. Author IS and RD have no conflicts of interest to declare.
